| Financial Year |
March 31 2023 |
| Monetary Funds |
36,169,551,172.80 |
| Held-for-trading Financial Assets |
1,154,768,785.44 |
| Notes Receivable |
8,821,972,403.70 |
| Accounts Receivable |
25,544,083,439.80 |
| Advances to Suppliers |
19,372,669,923.65 |
| Other Receivables |
5,440,481,468.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
151,327,792.82 |
| Dividend Receivable |
80,564,382.23 |
| Inventories |
6,985,610,661.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,911,334,897.74 |
| Other Current Assets |
3,336,428,873.39 |
| Total Current Assets |
154,728,230,378.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,093,656,962.33 |
| Long-term Equity Investment |
2,312,395,592.93 |
| Investment Properties |
1,479,740,061.38 |
| Fixed Assetes |
15,189,749,147.33 |
| Under-construction Projects |
2,334,915,752.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,925,887,550.06 |
| R&D expenses |
10,176,204.66 |
| Goodwill |
19,541,389.96 |
| Long-Term Deferred and Prepaid Expenses |
458,465,202.06 |
| Deferred Income Tax Assets |
1,176,091,599.26 |
| Other Non-Current Assets |
3,444,524,805.65 |
| Sub-Total of Non-Current Assets |
44,714,919,443.07 |
| Total Assets |
199,443,149,821.66 |
| Short-Term Loans |
544,011,689.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,886,968,784.47 |
| Accounts Payable |
64,704,810,898.61 |
| Accounts Received In Advance |
25,133,849.59 |
| Employee Compensation Payable |
187,782,258.35 |
| Taxes Payable |
1,068,967,846.36 |
| Interest Payable |
145,064,107.06 |
| Dividend Payable |
3,543,866.38 |
| Other payables |
10,335,456,537.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
163,641,324.30 |
| Other Current Liabilities |
5,051,306,848.65 |
| Sub-Total of Current Liabilities |
128,358,256,002.74 |
| Long-term Loans |
7,545,582,303.17 |
| Bonds Payable |
699,963,018.87 |
| Long-Term Accounts Payable |
115,885,876.77 |
| Special Payable |
-- |
| Estimatied Liabilities |
184,892,113.50 |
| Deferred Income Tax Liabilities |
172,587,706.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,480,554,191.02 |
| Total Liabilities |
139,838,810,193.76 |
| Paid-In Capital(Or Share Stock) |
6,109,470,588.00 |
| Capital Surplus |
15,326,361,650.44 |
| Surplus Reserve |
2,425,182,569.59 |
| LESS:Treasury Stock |
510,035,214.57 |
| Undistributed Profits |
30,629,025,857.98 |
| Minority Stockholder's Interest |
5,559,720,965.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
54,044,618,662.18 |
| Owner's Equity（Stockholder's Equity） |
59,604,339,627.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
199,443,149,821.66 |
